/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/5ed622ef8cb62a041c7fddf8/2023-04-20-13-48-24-377-644142a8bf1c96c8a3c3edd2.jpg)
In the latest episode of At the Intersection of Science and Law, Roberto Valenti and Raymond Miller discuss trade secrets protection in...
Cortex - Life Sciences Insights
Following the 2010 adoption of the US ‘Sunshine Act’, several EU member states have recently introduced statutory obligations for life...
Between 9 and 11 April I will be in Basilea with Johan Renes from DLA Piper Amsterdam and Paula Gonzalez from DLA Piper Madrid at the...
Really looking forward to meeting you at the IP Forum for Life Sciences in April. I will be hosting a discussion with tregard to naming...
For the first time, in Eli Lilly v Actavis the UK Supreme Court has introduced a doctrine of equivalence in an effort to move closer to...
In the near future the European Medicines Agency (EMA), the agency responsible for the scientific evaluation, supervision and safety...
